Giancarla Gerli

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis

Giovanni Barosi, Gaetano Bergamaschi, Monia Marchetti et al. · Blood · 2007 · 253 citations · Full text

Medicine, Genetics, Hematology +14

Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis

Claudia Vener, Nicola Stefano Fracchiolla, Umberto Gianelli et al. · Blood · 2007 · 85 citations · Full text

Medicine, Clinical Sciences, Pathology +17

Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia

Valerio De Stefano, Tommaso Zà, Elena Rossi et al. · American Journal of Hematology · 2009 · 67 citations · Full text

Medicine, Hematology, Internal Medicine +14

Erythrocyte antioxidant system in Down syndrome

Giancarla Gerli, Luca Zenoni, Giovanni F. Locatelli et al. · American Journal of Medical Genetics · 2005 · 26 citations

Life Sciences, Biochemistry, Hematology +17

Erythrocyte Antioxidant Activity, Serum Ceruloplasmin, and Trace Element Levels in Subjects with Alcoholic Liver Disease

Giancarla Gerli, Giovanni F. Locatelli, R Mongiat et al. · American Journal of Clinical Pathology · 1992 · 25 citations

Medicine, Biochemistry, Hematology +16